
Sign up to save your podcasts
Or


Global Extended Reality Market size expected to grow from 33 billion USD in 2021 to over 125 billion USD in 2026, at CAGR of 30%
US online sports betting market size expected to grow at 50% CAGR to reach 15 billion by 2025
Online gambling market size expected to grow at 11.5% CAGR to reach 127 billion USD by 2027
XR Casino, Inc. (“XR Casino” or “The Company”), the first-ever cross-technology, multiplayer, blockchain technology-based online gambling platform for Extended Reality (“XR”) technologies such as Augmented Reality (“AR”), Mixed Reality (“MR”) and Virtual Reality (“VR”), today announces its MVP release date.
To read the original press release, visit: https://nnw.fm/10QVT
Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (FSE: 0RW) (OTC: RRSFF), a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Rritual's recent announcement that its premium brand of functional superfoods will launch in CVS stores across the USA.
To hear the audio production, visit: https://www.nnw.fm/bFP7j
To read the original press release, visit: https://www.nnw.fm/V9sYE
Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (FSE: 0RW) (OTC: RRSFF), a fast-growing functional superfood company that creates natural wellness products which support a holistic approach to a healthy lifestyle, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers Rritual's recent announcement that its premium brand of functional superfoods will launch in CVS stores across the USA.
To hear the audio production, visit: https://www.nnw.fm/bFP7j
To read the original press release, visit: https://www.nnw.fm/V9sYE
In May 2013, GW Pharma listed on Nasdaq, selling 3.5 million shares at $8.90 each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds. Legal cannabis was only beginning to gain momentum at that time, and while countless companies saturated the market as would-be growers, distributors, etc., GW was taking a more difficult route of drug development with much greater upside if successful. The strategy paid off as the company received FDA approval for the first-ever cannabis-based drug in June 2018. There are some notable similarities between the evolution of the legal cannabis market a decade ago and the current status of psychedelics, longtime illicit drugs that are now being evaluated for their therapeutic potential by a handful of upstart companies. San Diego-based Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (Profile) stands out, not only for its still-small valuation but also because it has a successful management team that, much like GW, is charting its own course in the space. Major investors have not been shy about speculating that biotech is going to produce some psychedelic-derived blockbusters, as evidenced by the attention given to COMPASS Pathways Plc (NASDAQ: CMPS), Mind Medicine (“MindMed”) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and newly public ATAI Life Sciences N.V. (NASDAQ: ATAI), any one of which could do for psychedelics what GW Pharmaceuticals (NASDAQ: GWPH) did for cannabis before being acquired in February by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for $7.2 billion.
From the publisher's feed

640 Listeners